Assessment of progress after Edinburgh Essential Medicines Statement

Response to this request is long overdue. By law, under all circumstances, Edinburgh Innovations Limited should have responded by now (details). You can complain by requesting an internal review.

rachel mccormick

Dear Edinburgh Innovations,

For the following request, please use the following definitions:

A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.1
Licence: Permission for the licensee to use the intellectual property rights2
Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.3
Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.4
Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organised knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’5
Non-Disclosure agreement: A non-disclosure agreement is a legally binding contract that establishes a confidential relationship. The party or parties signing the agreement agree that sensitive information they may obtain will not be made available to any others. An NDA may also be referred to as a confidentiality agreement.6

1https://www.upcounsel.com/what-is-a-pate...
2-3 https://www.taylorwessing.com/synapse/co...
4https://www.euro.who.int/en/health-topic...
5https://www.investopedia.com/terms/n/nda...
6https://www.ed.ac.uk/files/atoms/files/e...

Under the Freedom of Information Act 2000, please provide me with information on the following:

START FOI
In concordance with the Edinburgh Essential Medicines Position Statement6, please link the following:
1. Where “information concerning negotiations regarding technology transfer with a third party, the specific health technology concerned, and the identity of the third party” is publicly available,
2. Where technology transfer agreements are published in full/ as redacted versions,

Additionally, please state whether a “committee that monitors and promotes the adherence to the goals and provisions committed to by the University of Edinburgh in this policy” was established and if so, how many meetings there have been.

END FOI
Yours Sincerely,

Rachel McCormick

Mail Delivery System,

2 Attachments

  • Attachment

    attachment.delivery status

    0K Download

  • Attachment

    Freedom of Information request Assessment of progress after Edinburgh Essential Medicines Statement.txt

    3K Download View as HTML

This message was created automatically by mail delivery software.

A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:

[email address]
host rhine.is.ed.ac.uk [129.215.17.201]
SMTP error from remote mail server after RCPT TO:<[email address]>:
550 5.1.1 <[email address]>... User unknown

Sent request to Edinburgh Innovations Limited again, using a new contact address.